section name header

Pronunciation

a-MILL-oh-ride

Classifications

Therapeutic Classification: diuretics, potassium sparing diuretics

Indications

REMS


Action

  • Inhibition of sodium resorption in the kidney, saving potassium and hydrogen ions.
Therapeutic effects:
  • Weak diuretic and antihypertensive response when compared with other diuretics.
  • Conservation of potassium.

Pharmacokinetics

Absorption: 30–90% absorbed.

Distribution: Widely distributed.

Metabolism/Excretion: 50% eliminated unchanged in urine, 40% excreted in the feces.

Half-Life: 6–9 hr.

Time/Action Profile

(diuretic effect)

ROUTEONSETPEAKDURATION
PO2 hr6–10 hr24 hr



Single dose.



Contraind./Precautions

Contraindicated in:

Use Cautiously in:

Adv. Reactions/Side Effects

CV: arrhythmias

F and E: hyperkalemia, hyponatremia

GI: constipation, nausea, vomiting

MS: muscle cramps

Neuro: dizziness, headache

Misc: allergic reactions

Interactions

Drug-drug:

Route/Dosage

Availability

(Generic available)

Assessment

Lab Test Considerations:

Implementation

Patient/Family Teaching

Evaluation/Desired Outcomes

Canadian Brand Names

Midamor